Diagnostic Products Corp.
Industry
- In Vitro Diagnostics
- Chemistry, Immunoassay
- Biotechnology
Latest on Diagnostic Products Corp.
While over-treating still remains a major problem in addressing prostate cancer, science continues to improve the task of identifying which patients actually need treatment as well as clarifying what
SHANGHAI – China says it will launch a three-month crackdown on commercial bribery with a particular focus on drug sales, distribution and medical services in a drive that could be a prelude to wider
The numbers are almost as startling as the controversy. One in six men will develop prostate cancer in their lifetime, with nearly 240,000 American men expected to be diagnosed this year, according to
As befits this struggling economy, each of the Big Three in diagnostic imaging sounded downbeat in their 2008 year-end financial assessments. Siemens AG saw declining orders for imaging equipment